TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman
- Sponsor
- Oman Ministry of Health
- Study ID
- NCT07721129
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Ischemic Stroke
- Ischemic Stroke, Acute
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- alteplase or tenecteplase — DRUGThrombolysis using TeleStroke consultation with Neurologist
Study Details
The goal of this study is to establish and examine the efficacy of using a Telestroke network in Oman to facilitate using emergent thrombolysis for patients with acute ischemic stroke encountered in selected peripheral hospitals. It is proposed to establish a TeleStroke network involving two central hospitals in Muscat linked to three to five peripheral hospitals in Oman which currently have access to CT scans and basic infrastructure for management of AIS patients- but do not have a Neurology service. Selected staff from Internal Medicine/Emergency Medicine departments, Nursing, Technical service and support staffs will be trained in the process of assessment and management of AIS patients including the use of IV alteplase or tenecteplase. They will also be trained in timely access of a Neurologist on call at the central hospital(s) using a TeleStroke network. The Neurologist would conduct a Telestroke based clinical assessment of the AIS patient, review imaging and laboratory results in a timely manner and advice the medical team at the peripheral hospital regarding administration of IV alteplase/tenecteplase. The main purpose of such consultation would be to recognize eligible patients for administration of IV thrombolysis safely at the earliest opportunity within 4.5 hours, leading to increased rates of such thrombolysis with expected improved outcomes. Outcomes would be compared among 100 patients with AIS managed across these 5 hospitals prior to initiation of the practice of thrombolysis and at least 100 patients treated each with IV alteplase using TeleStroke Consultation with Neurologist. Demonstration of efficacy of TeleStroke based stroke thrombolysis would lead to effective implementation of this practice in Oman.
Key Dates
- First listed
- Jul 22, 2026
- Start date
- Aug 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 30, 2026
- Completion
- Mar 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Thrombolysis armThis arm includes patients with Acute ischemic stroke treated with thrombolysis using TeleStroke consultation
- No Intervention: Control ArmThis arm includes age, gender matched patients with Acute Ischemic stroke who are not treated by thrombolysis.
Primary Outcome Measure
90 day outcome [ Time Frame: 90 days ]
Central Contacts
- Arunodaya R Gujjar, MD, FRCP+968 95154022
- Ali Al-Belushi, MD+96896069012
Find similar trials
Related Studies
- Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular DisordersRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Stroke Recovery Initiative - Registry for Stroke Research StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Verapamil for Neuroprotection in StrokePHASE1/PHASE2 · Recruiting · Global Neurosciences Institute · Atlantic City, New Jersey
- The Recovery in Stroke Using PAP StudyRecruiting · Yale University · New Haven, Connecticut